IKONISYS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.43 EUR | 0.00% |
|
0.00% | -8.33% |
| 02-19 | Ikonisys Says Hospitex Wins Italian Tender for Diagnostic Systems | MT |
| 01-02 | Ikonisys: production record for Hospitex | CF |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 27.5 | 13.75 | 14.95 | 14.95 | - |
| Enterprise Value (EV) 1 | 27.5 | 13.75 | 16.55 | 14.95 | 11.15 |
| P/E ratio | -48.3 x | -5.62 x | -8.94 x | 71.5 x | 11.9 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 59.2 x | 14.7 x | 14.9 x | 3.05 x | 1.26 x |
| EV / Revenue | 59.2 x | 14.7 x | 16.5 x | 3.05 x | 0.94 x |
| EV / EBITDA | -82.9 x | -5.7 x | -23.6 x | 18.7 x | 4.64 x |
| EV / FCF | -20.3 x | -12 x | -8.71 x | 9.34 x | 2.93 x |
| FCF Yield | -4.94% | -8.36% | -11.5% | 10.7% | 34.1% |
| Price to Book | 1.37 x | - | 1.01 x | 0.99 x | 0.91 x |
| Nbr of stocks (in thousands) | 9,482 | 9,482 | 10,451 | 10,451 | - |
| Reference price 2 | 2.900 | 1.450 | 1.430 | 1.430 | 1.430 |
| Announcement Date | 29/04/22 | 29/04/23 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | 0.4642 | 0.9352 | 1 | 4.9 | 11.9 |
| EBITDA 1 | -0.3317 | -2.411 | -0.7 | 0.8 | 2.4 |
| EBIT 1 | -0.4123 | -2.435 | -1.8 | 0.2 | 1.5 |
| Operating Margin | -88.81% | -260.34% | -180% | 4.08% | 12.61% |
| Earnings before Tax (EBT) 1 | -0.4174 | -2.448 | -1.9 | 0.2 | 1.5 |
| Net income 1 | -0.5713 | -2.448 | -1.9 | 0.2 | 1.5 |
| Net margin | -123.05% | -261.79% | -190% | 4.08% | 12.61% |
| EPS 2 | -0.0600 | -0.2582 | -0.1600 | 0.0200 | 0.1200 |
| Free Cash Flow 1 | -1.357 | -1.149 | -1.9 | 1.6 | 3.8 |
| FCF margin | -292.39% | -122.87% | -190% | 32.65% | 31.93% |
| FCF Conversion (EBITDA) | - | - | - | 200% | 158.33% |
| FCF Conversion (Net income) | - | - | - | 800% | 253.33% |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 29/04/22 | 29/04/23 | - | - | - |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | 1.6 | - | - |
| Net Cash position 1 | - | - | - | - | 3.8 |
| Leverage (Debt/EBITDA) | - | - | -2.286 x | - | - |
| Free Cash Flow 1 | -1.36 | -1.15 | -1.9 | 1.6 | 3.8 |
| ROE (net income / shareholders' equity) | -3.26% | - | -11.4% | 1.2% | 8.3% |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share 2 | 2.110 | - | 1.420 | 1.440 | 1.570 |
| Cash Flow per Share 2 | -0.0800 | - | -0.1000 | 0.1500 | 0.3600 |
| Capex 1 | 0.58 | 0.86 | 1.2 | 0.6 | 0.9 |
| Capex / Sales | 124.07% | 92.29% | 120% | 12.24% | 7.56% |
| Announcement Date | 29/04/22 | 29/04/23 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.43
EUR
Average target price
6.3
EUR
Spread / Average Target
+340.56%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.33% | 15.96M | |
| +0.89% | 12.8B | |
| -10.29% | 7.61B | |
| +1.78% | 5.41B | |
| -1.16% | 4.51B | |
| +5.74% | 4.49B | |
| -50.70% | 3.29B | |
| +12.21% | 2.73B | |
| -16.13% | 2.02B | |
| -11.50% | 1.73B |
- Stock Market
- Equities
- ALIKO Stock
- Financials Ikonisys S.A.
